{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-109295","form_type":"8-K","ticker":"EWTX","cik":"0001710072","company_name":"Edgewise Therapeutics, Inc.","filed_at":"2025-11-10T23:59:59+00:00","discovered_at":"2026-05-14T18:02:40.227942+00:00","generated_at":"2026-05-16T22:29:05.232481+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Edgewise Therapeutics appoints Michael Nofi as CFO, succeeding retiring CFO Carruthers","bullets":["Michael Nofi appointed CFO effective Nov 10, 2025; replaces R. Michael Carruthers who retired.","Nofi's annual base salary: $465,000, target cash bonus 40% of salary, plus stock option for 262,500 shares and 43,750 RSUs.","Carruthers to remain employee until Jan 31, 2026, then consultant through Oct 31, 2026, with continued equity vesting.","Nofi previously Chief Accounting Officer at SpringWorks Therapeutics; brings 30+ years life sciences finance experience.","No disagreement between Carruthers and company; transition supports Edgewise's late-stage clinical and commercialization prep."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-109295","json":"https://secwatch.observer/filing/0001104659-25-109295.json","markdown":"https://secwatch.observer/filing/0001104659-25-109295.md","text":"https://secwatch.observer/filing/0001104659-25-109295.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1710072/000110465925109295/0001104659-25-109295-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1710072/000110465925109295/tm2530663d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T22:29:05.232481+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}